Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V10932 | AM-36 | 199467-52-2 | AM-36 is a novel and potent Na+ channel blocker, antioxidant agent |
![]() |
V8147 | AM-4668 | 1011531-27-3 | AM-4668 is a GPR40 agonist being studied in type 2 diabetes. |
![]() |
V10935 | AM-5262 | 1222088-90-5 | AM-5262 is a Potent GPR40 Full Agonist with improved rat PK profile and general selectivity profile. |
![]() |
V10937 | AM-643 Free Acid | 1233114-22-1 | AM-643 Free Acid is a novel and potent bioactive compound |
![]() |
V10938 | AM-6761 | 1584732-36-4 | AM-6761 is a novel and potent inhibitor of the MDM2-p53 |
![]() |
V9466 | AM-679 | 1206880-66-1 | AM679 is a potent and specific inhibitor of 5-lipoxygenase-activating protein (FLAP) with IC50 of 2 nM in a human membrane binding assay. |
![]() |
V10940 | AM-694 | 335161-03-0 | AM-694 is a novel and potent agonist for the cannabinoid receptor CB1 |
![]() |
V7643 | AM-8191 HCl | 1417548-17-4 | AM8191 is an orally bioactive bactericide that selectively inhibits DNA synthesis and Staphylococcus aureus gyrase (IC50=1.02 μM) and topo IV (IC50=10.4 μM). |
![]() |
V6269 | AM-8508 | 1338483-67-2 | AM-8508 is a novel and potent PI3Kδ inhibitor |
![]() |
V10942 | AM-8553 | 1352064-70-0 | AM-8553 is an MDM2/p53 inhibitor (KD: 0.4 nM for MDM2). |
![]() |
V8814 | AM-8735 | 1429386-01-5 | AM-8735 is a potent and specific MDM2 inhibitor (antagonist) with IC50 of 25 nM. |
![]() |
V8276 | AM-9514 | 1442677-18-0 | AM-9514 is a novel and potent Glucokinase (GK) activator |
![]() |
V10944 | AM-9635 | 1338483-10-5 | AM-9635 is a novel and potent PI3Kδ inhibitor |
![]() |
V11258 | AM-TS23 | 1489285-17-7 | Procaspase-IN-5 is a human DNA polymerase lambda inhibitor. |
![]() |
V10924 | AM211 | 1175526-27-8 | AM211 is a potent, selective, orally bioavailable prostaglandin receptor (DP2) antagonist (inhibitor) with IC50s of 4.9 nM, 7.8 nM, and 4.9 nM for human, mouse, guinea pig, and rat DP2, respectively. |
![]() |
V9208 | AM281 | 202463-68-1 | AM281 is a selective CB1 receptor blocker (antagonist) with IC50 of 9.91 nM. |
![]() |
V10934 | AM4113 | 614726-85-1 | CB1 antagonist 2 Obtained from patent WO2016184310A1, the caimabinoid 1 (CB1) antagonist, compound 3, inhibits CB1 in vivo with IC50 of 25.5 nM. |
![]() |
V8159 | AM6538 | 1245626-00-9 | AM6538 is a long-acting, high-affinity, pseudo-irreversible cannabinoid (CB) antagonist. |
![]() |
V22556 | AM6701 | 1010096-65-7 | AM6701 is a potent FAAH/MAGL inhibitor (equivalent inhibition IC50= 1.2 nM) with neuro-protective (neuro-protection) effects. |
![]() |
V6993 | AM7499 | 1577226-19-7 | AM7499 is a novel and potent cannabinoid receptor agonist |